CH Biotech R&D Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	631.83	394.13	478.86	939.93	530.02	321.01
Short-Term Investments	-	3.14	3.28	3.07	3.07	5.78
Cash & Short-Term Investments	631.83	397.27	482.13	943	533.1	326.79
Cash Growth	-4.38%	-17.60%	-48.87%	76.89%	63.13%	-0.93%
Accounts Receivable	479.45	246.02	162.83	106.07	33.3	161.14
Other Receivables	0.81	53.59	56.62	44.8	42.97	29.13
Receivables	480.26	299.61	219.45	150.87	76.27	190.27
Inventory	140.4	153.48	122.1	119.21	177.26	125.01
Prepaid Expenses	10.51	18.93	26.5	18.59	12.99	10.74
Other Current Assets	87.8	2.31	2.4	3.76	4.07	1.71
Total Current Assets	1,351	871.59	852.59	1,235	803.69	654.53
Property, Plant & Equipment	2,617	2,631	2,718	2,361	2,365	2,349
Long-Term Investments	26.17	26	29.1	29.36	-	-
Goodwill	-	2.45	2.45	2.45	2.45	2.45
Other Intangible Assets	14.69	8.75	3.43	3.71	5.82	5.39
Long-Term Deferred Tax Assets	6.5	6.79	2.84	3.21	2	2.23
Other Long-Term Assets	53.04	27.59	20.7	14.37	16.08	15.24
Total Assets	4,068	3,574	3,629	3,649	3,195	3,029
Accounts Payable	12.21	9.04	8.84	9.26	9.62	20.71
Accrued Expenses	-	0.19	0.23	0.35	0.41	0.19
Short-Term Debt	360	365	290	190	120	188
Current Portion of Long-Term Debt	-	107.28	107.28	385.6	120	140.76
Current Portion of Leases	25.33	25.56	24.33	28.18	21.62	16.83
Current Income Taxes Payable	171.84	66.8	54.11	119.28	76.02	68.35
Current Unearned Revenue	1.05	0.17	0.32	0.47	0.3	0.35
Other Current Liabilities	685.65	147.47	161.82	149.19	119.56	93.66
Total Current Liabilities	1,256	721.51	646.93	882.32	467.52	528.84
Long-Term Debt	-	31.98	189.26	-	385.6	523.18
Long-Term Leases	134.61	134.5	136.46	241.38	247.66	253.51
Pension & Post-Retirement Benefits	-	-	7.2	5.36	4.26	-
Long-Term Deferred Tax Liabilities	-	-	2.38	-	2.56	-
Other Long-Term Liabilities	0.48	0.48	0.21	-	-	-
Total Liabilities	1,391	888.48	982.44	1,129	1,108	1,306
Common Stock	1,028	1,028	1,028	1,028	970.83	844.2
Additional Paid-In Capital	718.75	718.53	718.26	717.64	331.32	331.32
Retained Earnings	914.78	930.12	877.19	771.2	782.37	570.21
Comprehensive Income & Other	15.11	9.35	22.42	3.3	3.16	-22.52
Total Common Equity	2,677	2,686	2,646	2,520	2,088	1,723
Minority Interest	-	-	0.87	-	-	-
Shareholders' Equity	2,677	2,686	2,647	2,520	2,088	1,723
Total Liabilities & Equity	4,068	3,574	3,629	3,649	3,195	3,029
Total Debt	519.94	664.33	747.33	845.16	894.89	1,122
Net Cash (Debt)	111.9	-267.05	-265.19	97.84	-361.79	-795.48
Net Cash Per Share	-	-2.59	-2.57	1.00	-3.67	-8.11
Filing Date Shares Outstanding	-	102.8	102.8	102.8	97.08	97.08
Total Common Shares Outstanding	-	102.8	102.8	102.8	97.08	97.08
Working Capital	94.72	150.08	205.66	353.1	336.16	125.69
Book Value Per Share	-	26.13	25.74	24.52	21.50	17.75
Tangible Book Value	2,662	2,675	2,640	2,514	2,079	1,715
Tangible Book Value Per Share	-	26.02	25.68	24.46	21.42	17.67
Land	-	502.39	546.51	143.24	143.26	109.81
Buildings	-	2,018	1,949	1,905	1,864	1,448
Machinery	-	892.56	823.54	576.15	476.33	358.65
Construction In Progress	-	35.68	40.12	60.5	73.28	508.86